Chemotherapy News

Amrubicin Receives FDA Fast Track Designation For The Treatment Of Small Cell Lung Cancer After First-Line Chemotherapy

Sat, 06 Sep 2008 12:14:49 +0200

Celgene Corporation (NASDAQ: CELG) announced that Amrubicin has been granted Fast Track product designation by the U.S. Food and Drug Administration (FDA) for the treatment of small cell lung cancer after first-line chemotherapy.

Bandwidth saved by RSScache.com

[Ad] Oprah's Superfood of the Year!

Detoxify and Lose Weight with AcaiPure - Click Here for Free Trial

Celgene receives FDA 'fast track' for Amrubicin in small cell lung cancer after first-line chemotherapy (News-Medical-Net)

Thu, 04 Sep 2008 13:09:50 +0200

Celgene Corporation today announced that Amrubicin has been granted Fast Track product designation by the U.S. Food and Drug Administration (FDA) for the treatment of small cell lung cancer after first-line chemotherapy.

Bandwidth saved by RSScache.com

Cognitive Challenges for Women Undergoing Adjuvant Chemotherapy for Treatment for Breast Cancer: The Role of Rehabilitation Oncology

Breast cancer is the most common malignancy and the second leading cause of cancer-related death in women in the United States.1 Adjuvant chemotherapy continues to be the mainstay of treatment for many types of breast cancer, improving the cure rate and prolonging survival. However, chemotherapy ...

Bandwidth saved by RSScache.com

Implementation of intraperitoneal chemotherapy for the treatment of ovarian cancer.

In January 2006, a clinical announcement made by the National Cancer Institute suggested that intraperitoneal chemotherapy become standard care for patients with newly diagnosed stage III, optimally debulked epithelial ovarian cancer. Intraperitoneal chemotherapy is new to many healthcare providers ...

Bandwidth saved by RSScache.com

Breast cancer chemotherapy: who can benefit?

BREAST CANCER CHEMOTHERAPY: Who Can Benefit? Women seeking a second opinion on the question of breast cancer chemotherapy often receive widely differing recommendations that can be both confusing and upsetting. In New York City, for example, oncologists at one leading cancer center advise a ...

Bandwidth saved by RSScache.com

New Surviving with Confidence Program Helps to Dispel Misconceptions About Chemotherapy Revealed in National Survey of Cancer Survivors.

- 83% of cancer survivors said they were at least somewhat fearful before undergoing chemotherapy, but only 38% feel their fears were justified - 90% of survivors said chemotherapy gave them hope for survival - 94% of survivors advise other survivors to undergo chemotherapy if their doctor ...

Bandwidth saved by RSScache.com

Early Prediction of Response to Chemotherapy in Metastatic Breast Cancer Using Sequential ^sup 18^F-FDG PET

Chemotherapy is currently the treatment of choice for patients with high-risk metastatic breast cancer. Clinical response is determined after several cycles of chemotherapy by changes in tumor size as assessed by conventional imaging procedures including CT, MRI, plain film radiography, or ...

Bandwidth saved by RSScache.com

Neoadjuvant Chemotherapy in Stage III Breast Cancer

Neoadjuvant chemotherapy in advanced breast cancer can potentially downstage disease prior to definitive surgery. In this study, a doxorubicin-based neoadjuvant regimen was administered to stage III breast cancer patients to assess 1) primary tumor response, 2) tumor involvement of resection ...

Bandwidth saved by RSScache.com

Fatigue in women receiving intraperitoneal chemotherapy for ovarian cancer.

Women diagnosed with stage III or IV ovarian cancer typically are treated with surgery followed by chemotherapy. Intraperitoneal chemotherapy, the direct administration of chemotherapy into the IP cavity, has been explored as a viable treatment option for some women with advanced ovarian ...

Bandwidth saved by RSScache.com

Intraperitoneal chemotherapy: implications beyond ovarian cancer.

The National Cancer Institute announced in January 2006 the use of intraperitoneal combined with IV chemotherapy postoperatively as the preferred treatment method for advanced ovarian cancer. The announcement stimulated the need for oncology nurses to become familiar with IP chemotherapy ...

Bandwidth saved by RSScache.com

New Surviving with Confidence Program Helps to Dispel Misconceptions About Chemotherapy Revealed in National Survey of Cancer Survivors.

Bandwidth saved by RSScache.com

[Ad] “How To Lose Stomach Fat”

Finally, A Diet That Really Works! As Seen On CNN, CBS, NBC & Fox!

Implementation of intraperitoneal chemotherapy for the treatment of ovarian cancer.

Bandwidth saved by RSScache.com

Mitochondrial Cholesterol Makes Response To Chemotherapy Difficult In Hepatic Cancer

Tue, 15 Jul 2008 13:07:44 +0200

Cancer is a disease characterized by important metabolic alterations. Not only do these adaptative changes give higher proliferative capacity to cancer cells, but they also contribute to higher resistance to chemotherapeutic agents. The research group led by Dr.

Bandwidth saved by RSScache.com

Mitochondrial Cholesterol Makes Response To Chemotherapy Difficult In Hepatic Cancer

Tue, 15 Jul 2008 01:06:44 +0200

Researchers have demonstrated that the increase of cholesterol concentration in the mitochondrial membrane makes the action of chemotherapy difficult in cellular hepatocarcinoma. According to these results, drugs such as statins could sensitize cancer cells against chemotherapy since they diminish the level of mitochondrial cholesterol.

Bandwidth saved by RSScache.com

U-M study to look at effects of chemotherapy on brain function of breast cancer survivors (News-Medical-Net)

Tue, 08 Jul 2008 02:46:12 +0200

While Maria Lyzen was being treated for breast cancer, she found she couldn't concentrate or decipher information, and just functioning day-to-day at home was difficult.

Bandwidth saved by RSScache.com

Fatigue in women receiving intraperitoneal chemotherapy for ovarian cancer.

Bandwidth saved by RSScache.com

Advanced cancer patients often unaware of life expectancies, effects of chemotherapy, according to perspective (News-Medical-Net)

Wed, 11 Jun 2008 17:35:14 +0200

Patients with advanced cancer often are not aware of their life expectancies or the effect that chemotherapy will have on their lives, according to a perspective published on Wednesday in the Journal of the American Medical Association, USA Today reports.

Bandwidth saved by RSScache.com

Cancer Care Costs Climbed Between 1991 And 2002, As Radiation And Chemotherapy Increased

Wed, 11 Jun 2008 14:18:22 +0200

The cost of cancer care incurred during the period two months prior to cancer diagnosis and 12 months following diagnosis increased substantially between 1991 and 2002 for elderly patients in the United States, according to a study published online June 10 in the Journal of the National Cancer Institute.

Bandwidth saved by RSScache.com